British journal of clinical pharmacology
STRATIfy-PK SCORE: A predictive tool for identifying pharmacokinetic failure risk in anti-TNF-treated patient.
Carles Iniesta-Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo, Juan José Gascón-Cánovas, Maria Rocio González-Molina, Isabel Nicolás-De Prado, Rosa Gómez-Espín, Elena Urbieta-Sanz
Published: 202510.1002/bcp.70346
Abstract
OBJECTIVE: The purpose of this study is to identify risk factors associated with pharmacokinetic failure, defined as immunogenicity or subtherapeutic drug concentrations, in patients treated with infliximab (IFX) or adalimumab (ADA), and to develop a…
Preview only. Read the full abstract at the source